Authors' reply
| dc.contributor.author | Dizman, Nazli | |
| dc.contributor.author | Bahat, Kübra Aydin | |
| dc.contributor.author | Özkanli, Şeyma | |
| dc.contributor.author | Özkök, Abdullah | |
| dc.date.accessioned | 2025-05-10T15:22:30Z | |
| dc.date.issued | 2016 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | [No abstract available] | |
| dc.identifier.issn | 1016-5169 | |
| dc.identifier.issue | 6 | |
| dc.identifier.scopus | 2-s2.0-84986586563 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 538 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/6483 | |
| dc.identifier.volume | 44 | |
| dc.indekslendigikaynak | Scopus | |
| dc.language.iso | en | |
| dc.publisher | Turkish Society of Cardiology | |
| dc.relation.ispartof | Turk Kardiyoloji Dernegi Arsivi | |
| dc.relation.publicationcategory | Diğer | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_Scopus_20250302 | |
| dc.subject | corticosteroid; cyclophosphamide; atherosclerosis; cancer risk; cardiotoxicity; cardiovascular risk; cholesterol embolization syndrome; cholesterol embolization syndrome; corticosteroid therapy; human; Letter; lung toxicity | |
| dc.title | Authors' reply | |
| dc.type | Letter |
